Xenios AG - a Fresenius Medical Care company
Michael Schrader has extensive experience in the medical care industry. Michael started their career at Gambro in 1989, where they served as the National Manager of Group Sales until June 1999. In 2001, they joined NxStage Medical Inc. as the Vice President of Critical Care Sales, a role they held until recently. Currently, they are the Vice President of Critical Care Sales at Xenios AG - a Fresenius Medical Care company, where they have been working since July 2021.
Michael Schrader attended Eastern Illinois University from 1980 to 1982, where they earned a Bachelor of Science degree in Business with a focus on Marketing/Marketing Management, General.
This person is not in any teams
This person is not in any offices
Xenios AG - a Fresenius Medical Care company
At Xenios, a Fresenius Medical Care company, we offer ECMO treatments for patients suffering from cardiac and/or pulmonary failure. Based on a holistic understanding of human physiology, we develop intelligent technological solutions that can be vital for the survival of critically ill patients. We offer solutions that combine both cardiac and pulmonary support on one single technological platform. It supports the gas exchange in the lungs and the cardiovascular system to keep patients alive. The physician thus gains more vital treatment time during diagnosis and therapy. Xenios is part of Fresenius Medical Care, the world's leading provider of products and services for people with renal diseases. We are complementing Fresenius Medical Care’s product portfolio in the field of intensive care and are continuing to shape the future of extracorporeal multi-organ support. In our daily work, we share a passion for helping people. For patients. Worldwide. Every day.